Routine Molecular Screening of Patients with Advanced Non-SmallCell Lung Cancer in Circulating Cell-Free DNA at Diagnosis and During Progression Using OncoBEAM(TM)EGFR V2 and NGS Technologies

BACKGROUND AND OBJECTIVES: The use of ultra-sensitive diagnostic tests to detect clinically actionable somatic alterations within the gene encoding the epidermal growth factor receptor (EGFR) within circulating cell-free DNA is an important first step in determining the eligibility of patients with...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Mol Diagn Ther
Asıl Yazarlar: Garcia, Jessica, Gauthier, Arnaud, Lescuyer, Gaëlle, Barthelemy, David, Geiguer, Florence, Balandier, Julie, Edelstein, Daniel L., Jones, Frederick S., Holtrup, Frank, Duruisseau, Mickael, Grolleau, Emmanuel, Rodriguez-Lafrasse, Claire, Merle, Patrick, Couraud, Sébastien, Payen, Léa
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Springer International Publishing 2021
Konular:
Original Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7956937/
https://ncbi.nlm.nih.gov/pubmed/33660188
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40291-021-00515-9
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller